Bottom line
Is MAIRX a good fund? The bottom line
MAIRX is the Class R6 share class of Victory Trivalent International Fund - Core Equity, a managed international stock mutual fund from Victory Capital.
Annual fees run 0.55% — about $55 a year on every $10,000 invested, cheaper than 81% of international stock funds we track.
It returned +37.3% over one year, +10.3% a year over five years (as of Dec 31, 2024, per its prospectus).
With $336 million in net assets and 210 holdings, its largest position is Taiwan Semiconductor Manufacturing Company Limited (4.4%) and the top 10 make up 20.8% of the portfolio.
What stands out
- Low cost: cheaper than 81% of international stock peers
- 5-year return beat 84% of category peers
- Broadly diversified (210 holdings)
- No front-end sales load
Updated Nov 19, 2026
What MAIRX invests in
The Victory Trivalent International Fund Core Equity (the Fund) seeks to provide long-term growth of capital.
The Adviser pursues the Fund's investment objective by investing primarily in equity securities of companies in countries represented in the MSCI ACWI ex USA Index (Index), but also may invest in companies from other countries. Under normal circumstances, the Fund invests at least 80% of its net assets (plus the amount of borrowings, if any, for investment purposes) in equity securities. The Adviser employs a bottom-up investment approach that emphasizes individual stock selection. The Adviser's investment process uses a combination of quantitative and traditional qualitative, fundamental analysis to identify attractive stocks with low relative price multiples, positive trends in earnings forecasts, high profitability, and companies with a strong or positively trending responsible investing (RI) profile. The stock selection process is designed to produce a diversified portfolio that…
From the fund's prospectus (filed Oct 26, 2026).
MAIRX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| MAIRX | +37.3% | +10.3% | — |
| International Stock median | +25.5% | +6.4% | +7.6% |
Source: Fund prospectus, as of Dec 31, 2024
What MAIRX costs
On a $10,000 investment, MAIRX's 0.55% expense ratio costs about $55 a year. The prospectus estimates $1,119 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.
MAIRX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Taiwan Semiconductor Manufacturing Company Limited | 4.44% |
| 2 | SK hynix Inc. | 3.47% |
| 3 | ASML Holding N.V. | 2.69% |
| 4 | Samsung Electronics Co., Ltd. | 2.42% |
| 5 | Novartis AG | 1.52% |
| 6 | Banco Santander, S.A. | 1.41% |
| 7 | Standard Chartered Plc | 1.26% |
| 8 | Astrazeneca Plc | 1.25% |
| 9 | Kioxia Holdings Corporation | 1.19% |
| 10 | ABB Ltd | 1.17% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 20.8% of the fund. See all top 25 holdings and asset mix →